| Structure | Chemical Name | CAS | MF |
|
LEWISITEOXIDEPOLYMER
|
|
|
|
LEWISITEL-2
|
40334-69-8
|
C4H4AsCl3
|
|
LEWISITEL-3
|
40334-70-1
|
C6H6AsCl3
|
|
lewisite
|
541-25-3
|
C2H2AsCl3
|
|
|
Lewis Y antigen
|
|
|
|
|
Lewis Blood-Group System
|
|
|
|
|
LEWISA,GALSS1-3[FUCA1-4],CLONE:B369,MABANTI-HUMAN
|
|
|
|
|
LewisAheptasaccharide
|
|
|
|
LewisBtetrasaccharide
|
80081-06-7
|
C26H45NO19
|
|
LewisYtetrasaccharide
|
82993-43-9
|
C26H45NO19
|
|
|
LEWIS A-BSA
|
|
|
|
LEWIS A TRISACCHARIDE, METHYL GLYCOSIDE TETRABENZYL ETHER
|
|
C49H61NO15
|
|
LEWIS A TRISACCHARIDE, METHYL GLYCOSIDE
|
186315-40-2
|
C18H32O15
|
|
Lewis X Trisaccharide, Methyl Glycoside
|
176106-81-3
|
C21H37NO15
|
|
LEWIS A TRISACCHARIDE
|
56570-03-7
|
C20H35NO15
|
|
|
LEWIS-Y-TETRASACCHARIDE-APE-HSA
|
|
|
|
LEWISY TETRASACCHARIDE ESTER
|
|
C33H57NO21
|
|
|
Lewis Acid Reagents: A Practical Approach
|
|
|
|
Lexacalcitol
|
131875-08-6
|
C29H48O4
|
|
|
Levulin
|
|
|
|
Levulinic acid hexyl ester
|
|
C11H20O3
|
|
|
Levulinic acid alkyl(C=12) ester
|
|
|
|
Levulinaldehyde, 2-methoxy- (6CI)
|
98485-51-9
|
C6H10O3
|
|
Levulinohydroxamic acid (6CI)
|
114983-43-6
|
C5H9NO3
|
|
Levulinaldehyde, 1-oxime (6CI)
|
98071-20-6
|
C5H9NO2
|
|
Levulinaldehyde, 2-hydroxy- (8CI)
|
34160-21-9
|
C5H8O3
|
|
LevulinicAcidCalciumSaltDihydrate,~99%
|
|
C10H18CaO8
|
|
LEVULINIC ACID SEMICARBAZONE
|
89532-09-2
|
C6H11N3O3
|
|
Levulinic acid
|
123-76-2
|
C5H8O3
|
|
|
Levulinic Acids
|
|
|
|
LEVULINIC ACID, (4-KETOPENTANOIC ACID; 4-OXOPENTANOIC ACID)
|
|
C15H24O9
|
|
LEVULINICACIDPHENYLHYDRAZONE
|
|
C11H14N2O2
|
|
LEVULINIC ACID CALCIUM SALT DIHYDRATE
|
5743-49-7
|
C10H18CaO8
|
|
LEVULINIC ACID PHENYLHYDRAZONE LACTAM
|
588-60-3
|
C11H14N2O2
|
|
4-Oxopentanal
|
626-96-0
|
C5H8O2
|
|
Lev u lose
|
57-48-7
|
C6H12O6
|
|
|
Levulinic acid ion(-1)
|
|
C5H7O3-1
|
|
Levulinic acid
|
123-76-2
|
C5H8O3
|
|
Levulinamide, N-methyl- (6CI)
|
98548-88-0
|
C6H11NO2
|
|
Levulinic acid, 5-chloro-2-methyl- (7CI,8CI)
|
2801-76-5
|
C6H9ClO3
|
|
Levulinic acid, 5-chloro-3-methyl- (7CI,8CI)
|
2801-77-6
|
C6H9ClO3
|
|
Levulinic acid propyl ester
|
|
C8H14O3
|
|
Levulinic acid allyl ester
|
|
C8H12O3
|
|
Levulinic acid tridecyl ester
|
|
C18H34O3
|
|
Levulinic acid phenyl ester
|
|
C11H12O3
|
|
L-4-Fluorophenylalanine
|
1132-68-9
|
C9H10FNO2
|
|
(S)-4-Fluorophenylglycine
|
19883-57-9
|
C8H8FNO2
|
|
|
L-2-FLUOROADENOSINE (9-(β-L-RIBOFURANOSYL)-2-FLUORO-6-AMINOPURINE)
|
|
|
|
L-2-FLUOROPHENYLALANINE HEMIHYDRATE
|
|
C9H12FNO3
|
|
L-2-FLUOROPHENYLALANINE HEMIHYDRATE, 99.5+%(E.E.)
|
205652-54-6
|
C9H10FNO2.H2O
|
|
L-(4-FLUOROPHENYL)ALANINE, HYDRATED
|
|
C9H12FNO3
|
|
L-3-Fluorotyrosine
|
|
C9H10FNO3
|
|
L-FLUOROPHENYLALANINE
|
|
C9H10FNO2
|
|
L-(2-FLUOROPHENYL)ALANINE, HYDRATE
|
|
C9H12FNO3
|
|
|
lexA protein
|
|
|
|
|
Lexatumumab
|
845816-02-6
|
|
|
L-Fmoc-Aspartic acid alpha-tert-butyl ester
|
129460-09-9
|
C23H25NO6
|
|
L-1-(FMOC-AMINO)-3-METHYLSULFANYL-1-(1-METHYL-1H-PYRROLE-2-CARBONYL)PROPANE
|
|
C25H26N2O3S
|
|
L-1-(FMOC-AMINO)-1-(1-METHYL-1H-INDOLE-3-CARBONYL)-3-METHYLSULFANYLPROPANE
|
|
C29H28N2O3S
|
|
L-1-(FMOC-AMINO)-3-METHYLSULFANYL-1-(1H-PYRROLE-2-CARBONYL)PROPANE
|
|
C24H24N2O3S
|
|
L-1-(FMOC-AMINO)-1-(1H-INDOL-3-YLMETHYL)-2-(1-METHYL-1H-INDOL-3-YL)-2-OXOETHANE
|
|
C35H29N3O3
|
|
L-1-(FMOC-AMINO)-2-(1H-INDOL-3-YL)-1-(1H-INDOL-3-YLMETHYL)-2-OXOETHANE
|
|
C34H27N3O3
|
|
L-1-(FMOC-AMINO)-1-METHYL-2-(1-METHYL-1H-INDOL-3-YL)-2-OXOETHANE
|
|
C27H24N2O3
|
|
L-1-(FMOC-AMINO)-1-(1H-INDOL-3-YLMETHYL)-2-OXO-2-(1-METHYL-1H-PYRROL-2-YL)ETHANE
|
|
C31H27N3O3
|
|
L-1-(FMOC-AMINO)-1-(1H-INDOLE-3-CARBONYL)-3-METHYLSULFANYLPROPANE
|
|
C28H26N2O3S
|
|
L(+)-FMOC-ORNITHINE HCL
|
201046-57-3
|
C20H23ClN2O4
|
|
L-1-(FMOC-AMINO)-1-(1H-INDOL-3-YLMETHYL)-2-OXO-2-(1H-PYRROL-2-YL)ETHANE
|
|
C30H25N3O3
|
|
|
LEXEIN CP-125
|
308074-11-5
|
|
|
|
LGC1 protein
|
|
|
|
|
Lexglas(R) double burette holder
|
|
|
|
LEW 7S1
|
123580-52-9
|
C92H114N4O44
|
|
Lexil
|
63280-97-7
|
C37H40Br2N4O4
|
|
lexipafant
|
139133-26-9
|
C23H30N4O4S
|
|
|
Lexipafant
|
|
C23H30N4O4S
|
|
|
LEXIRIN
|
|
|
|
Lexiscan
|
875148-45-1
|
C15H20N8O6
|
|
|
Lexithromycin
|
|
|
|
lexitropsin 1
|
123725-00-8
|
C15H19N7O3S
|
|
lexitropsin
|
110124-49-7
|
C20H29N5O4
|
|
|
Le(y)-active trifucosylnonaosylceramide
|
104200-12-6
|
|
|
|
LEYBOLD TRIVAC ROTARY VANE PUMP D5.0E &
|
|
|
|
|
Leybold clamping ring for KF10/16 flange
|
|
|
|
|
Leybold KF16 flange with hose nozzle
|
|
|
|
|
Leybold centering ring for KF16 flange
|
|
|
|
|
Leybold Trivac(R) B direct-drive pumps
|
|
|
|
|
Leybold Trivac(R) E direct-drive pumps
|
|
|
|
|
LEYBOLD VACUUM PUMP OIL
|
64741-88-4
|
|
|
|
LEYBOLD VACUUM PUMP OIL
|
64742-65-0
|
|
|
|
leydin
|
|
|
|
|
Leydig insulin-like protein
|
|
|
|
Lexofenac
|
41387-02-4
|
C14H14O3
|
|
|
L.Extract
|
|
|
|
|
Lfpep peptide
|
|
|
|
|
L-4-F-Phg-OH L-4-Fluorophenylglycine
|
|
|
|
|
L-FormularAminoAcids
|
|
|
|
|
LGHALPHAIT,RECOMBINANT
|
|
|
|
|
LfrA protein
|
|
|
|
|
L-g-Glutamyl-p-nitroanilide
|
|
|
|
L-[G-3H]GLUTAMINE
|
|
C5N2O3T10
|
|
L-[G-3H]GLUTAMIC ACID
|
|
C5NO4T9
|